Published in Chembiochem on February 15, 2008
New strategies for fluorescent probe design in medical diagnostic imaging. Chem Rev (2010) 3.35
Telomeric repeat-containing RNA structure in living cells. Proc Natl Acad Sci U S A (2010) 1.23
Nucleic acid-based fluorescent probes and their analytical potential. Anal Bioanal Chem (2010) 1.00
A single-label phenylpyrrolocytidine provides a molecular beacon-like response reporting HIV-1 RT RNase H activity. Nucleic Acids Res (2009) 0.80
Competition-mediated pyrene-switching aptasensor: probing lysozyme in human serum with a monomer-excimer fluorescence switch. Anal Chem (2010) 0.77
Enzymatic amplification of DNA/RNA hybrid molecular beacon signaling in nucleic acid detection. Anal Biochem (2012) 0.76
Mercury(II) ion detection via pyrene-mediated photolysis of disulfide bonds. Chemistry (2012) 0.75
Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A (2006) 5.35
BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571. Blood (2003) 3.86
Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry (2006) 3.55
The role of anxiety and hormonal changes in menopausal hot flashes. Menopause (2005) 2.70
Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol (2007) 2.65
Development of DNA aptamers using Cell-SELEX. Nat Protoc (2010) 2.62
Selection of aptamers for molecular recognition and characterization of cancer cells. Anal Chem (2007) 2.57
Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition. Menopause (2005) 2.50
Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc Chem Res (2010) 2.48
Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J Proteome Res (2008) 2.44
Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake. Nat Neurosci (2013) 2.30
Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. Langmuir (2006) 2.17
Obesity and reproductive hormone levels in the transition to menopause. Menopause (2010) 2.10
Janus kinase 2: a critical target in chronic myelogenous leukemia. Cancer Res (2006) 1.99
Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol Cell Proteomics (2007) 1.98
Body size affects measures of ovarian reserve in late reproductive age women. Menopause (2008) 1.93
Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia. Cancer Res (2004) 1.90
Identification of liver cancer-specific aptamers using whole live cells. Anal Chem (2008) 1.90
A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles. Proc Natl Acad Sci U S A (2004) 1.87
Molecular engineering of DNA: molecular beacons. Angew Chem Int Ed Engl (2009) 1.84
Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells. Anal Chem (2008) 1.84
Cell-specific internalization study of an aptamer from whole cell selection. Chemistry (2008) 1.81
Light-switching excimer probes for rapid protein monitoring in complex biological fluids. Proc Natl Acad Sci U S A (2005) 1.80
Enrichment of cancer cells using aptamers immobilized on a microfluidic channel. Anal Chem (2009) 1.78
Aptamer-modified gold nanoparticles for colorimetric determination of platelet-derived growth factors and their receptors. Anal Chem (2005) 1.76
Optimization and modifications of aptamers selected from live cancer cell lines. Chembiochem (2007) 1.76
Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril (2006) 1.75
Ultrasensitive DNA detection using highly fluorescent bioconjugated nanoparticles. J Am Chem Soc (2003) 1.74
Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Chembiochem (2009) 1.73
Molecular recognition of small-cell lung cancer cells using aptamers. ChemMedChem (2008) 1.71
High-throughput single copy DNA amplification and cell analysis in engineered nanoliter droplets. Anal Chem (2008) 1.71
Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples. Clin Chem (2007) 1.69
TRPM8 mechanism of cold allodynia after chronic nerve injury. J Neurosci (2007) 1.69
Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab (2012) 1.67
In vivo study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal Chem (2008) 1.64
Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells. Anal Chem (2009) 1.61
Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis. BMC Med (2013) 1.61
Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. Anal Chem (2006) 1.58
DNA aptamer-micelle as an efficient detection/delivery vehicle toward cancer cells. Proc Natl Acad Sci U S A (2009) 1.56
Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. Anal Chem (2007) 1.55
Cancer cell targeting using multiple aptamers conjugated on nanorods. Anal Chem (2008) 1.55
Jak2 is involved in c-Myc induction by Bcr-Abl. Oncogene (2002) 1.54
Optimization of dye-doped silica nanoparticles prepared using a reverse microemulsion method. Langmuir (2004) 1.52
Process and technoeconomic analysis of leading pretreatment technologies for lignocellulosic ethanol production using switchgrass. Bioresour Technol (2011) 1.51
Locked nucleic acid molecular beacons. J Am Chem Soc (2005) 1.51
Molecular aptamer beacons for real-time protein recognition. Biochem Biophys Res Commun (2002) 1.49
Keeping donor hearts in completely beating status with normothermic blood perfusion for transplants. Ann Thorac Surg (2013) 1.48
Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alteration. Proc Natl Acad Sci U S A (2011) 1.48
Molecular assembly for high-performance bivalent nucleic acid inhibitor. Proc Natl Acad Sci U S A (2008) 1.44
DNA-functionalized nanotube membranes with single-base mismatch selectivity. Science (2004) 1.44
Aptamer-enabled efficient isolation of cancer cells from whole blood using a microfluidic device. Anal Chem (2012) 1.44
Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res (2009) 1.43
Carbon nanotube-quenched fluorescent oligonucleotides: probes that fluoresce upon hybridization. J Am Chem Soc (2008) 1.43
Hormones and sexuality during transition to menopause. Obstet Gynecol (2007) 1.42
Multicolor FRET silica nanoparticles by single wavelength excitation. Nano Lett (2006) 1.40
Aptamer switch probe based on intramolecular displacement. J Am Chem Soc (2008) 1.40
Bioconjugated nanoparticles for DNA protection from cleavage. J Am Chem Soc (2003) 1.39
Selective photothermal therapy for mixed cancer cells using aptamer-conjugated nanorods. Langmuir (2008) 1.37
DNA aptamers as molecular probes for colorectal cancer study. PLoS One (2010) 1.36
Uptake of silica-coated nanoparticles by HeLa cells. J Nanosci Nanotechnol (2005) 1.36
Assembly of aptamer switch probes and photosensitizer on gold nanorods for targeted photothermal and photodynamic cancer therapy. ACS Nano (2012) 1.32
Generating aptamers for recognition of virus-infected cells. Clin Chem (2009) 1.31
Duration of menopausal hot flushes and associated risk factors. Obstet Gynecol (2011) 1.31
Association between socio-psycho-behavioral factors and male semen quality: systematic review and meta-analyses. Fertil Steril (2010) 1.29
Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics. Proc Natl Acad Sci U S A (2013) 1.29
Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells. Cell Mol Life Sci (2010) 1.27
Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX. PLoS One (2010) 1.26
Noncanonical self-assembly of multifunctional DNA nanoflowers for biomedical applications. J Am Chem Soc (2013) 1.26
Synthetic DNA aptamers to detect protein molecular variants in a high-throughput fluorescence quenching assay. Chembiochem (2003) 1.26
Regulation of singlet oxygen generation using single-walled carbon nanotubes. J Am Chem Soc (2008) 1.23
Temporal associations of hot flashes and depression in the transition to menopause. Menopause (2009) 1.22
Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells. Analyst (2009) 1.22
Collection of trace amounts of DNA/mRNA molecules using genomagnetic nanocapturers. Anal Chem (2003) 1.21
Aptamer-nanoparticle strip biosensor for sensitive detection of cancer cells. Anal Chem (2009) 1.20
FloDots: luminescent nanoparticles. Anal Bioanal Chem (2006) 1.20
The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network. J Drug Target (2009) 1.20
Community health needs assessment with precede-proceed model: a mixed methods study. BMC Health Serv Res (2009) 1.20
Pyrene excimer signaling molecular beacons for probing nucleic acids. J Am Chem Soc (2007) 1.20
TAT conjugated, FITC doped silica nanoparticles for bioimaging applications. Chem Commun (Camb) (2004) 1.19
DNA-based micelles: synthesis, micellar properties and size-dependent cell permeability. Chemistry (2010) 1.18
Deactivation of cellulases by phenols. Enzyme Microb Technol (2010) 1.18
Ultrasensitive detection of biomolecules with fluorescent dye-doped nanoparticles. Anal Biochem (2004) 1.17
A deletion mutation in the betaA1/A3 crystallin gene ( CRYBA1/A3) is associated with autosomal dominant congenital nuclear cataract in a Chinese family. Hum Genet (2003) 1.16
An aptamer cross-linked hydrogel as a colorimetric platform for visual detection. Angew Chem Int Ed Engl (2010) 1.16
Predictors of sleep quality in women in the menopausal transition. Sleep (2008) 1.16